EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AVTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -4.739
March 31, 2026 -5.822
December 31, 2025 -6.096
September 30, 2025 -8.730
June 30, 2025 -9.377
March 31, 2025 -21.53
December 31, 2024 -161.42
September 30, 2024 -168.23
June 30, 2024 -192.23
March 31, 2024 -318.89
December 31, 2023 -381.56
September 30, 2023 -621.34
June 30, 2023 -513.13
March 31, 2023 -703.94
December 31, 2022 -1063.17
September 30, 2022 -1305.63
June 30, 2022 -1885.54
March 31, 2022 -2060.70
December 31, 2021 -2429.31
September 30, 2021 -2490.94
June 30, 2021 -2470.44
March 31, 2021 -2519.22
December 31, 2020 -2557.64
September 30, 2020 -2222.61
Date Value
June 30, 2020 -2120.49
March 31, 2020 -1992.41
September 30, 2019 -1532.02
June 30, 2019 -3358.05
March 31, 2019 -3518.73
December 31, 2018 -3448.40
September 30, 2018 -3664.11
June 30, 2018 -121.45
March 31, 2018 11.92
December 31, 2017 -178.19
September 30, 2017 28.80
June 30, 2017 -3484.80
March 31, 2017 -4262.40
December 31, 2016 -5414.40
September 30, 2016 -6422.40
June 30, 2016 -4637.03
March 31, 2016 -4428.26
December 31, 2015 -3809.52
September 30, 2015 -3639.40
June 30, 2015 -4619.55
March 31, 2015 -3647.52
June 30, 2014 -2567.06
March 31, 2014 -1210.78

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.220
Incyte Corp. 7.846
AbbVie, Inc. 3.537
Rezolute, Inc. -0.809
Alnylam Pharmaceuticals, Inc. 5.923